Abstract
This chapter examines the clinical aspects of pharmaceutical portfolio decision-making – a key driver of shareholder value – from the perspective of an Executive Committee reporting on portfolio strategy to a Board of Directors. Areas that are particularly important for shareholder value include a thorough evaluation of manufacturing and clinical drug development costs, commercial expectations, and the clinical risk/benefit assessment for each product. Other ways to evaluate risks associated with portfolio management include competitive intelligence, due diligence, patent protection and regulatory exclusivity. Portfolio managers must be aware of biases that can be inherent in portfolio decision-making, balancing those factors that may artificially increase or decrease the estimated probability of registration or commercial success. Complex tools, such as including adaptive design principles, and large data software tools can also be utilized to minimize and mitigate the risk and bias embraced by both the R&D and commercial factors
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Herper M (2011) The Best-Selling Drugs in America. Forbes, 19 Apr 2011. http://www.forbes.com/sites/matthewherper/2011/04/19/the-best-selling-drugs-in-america/. Accessed 24 Jul 2014
Staton T (2012) AZ’s Nexium tops Q2 sales ranks, with BMS’ Abilify on its heels. Forbes, 23 Aug 2012. http://www.fiercepharma.com/story/azs-nexium-tops-q2-sales-ranks-bms-abilify-its-heels/2012-08-23. Accessed 24 Jul 2014
Loftus P (2013) Eli Lilly enters unusual patent dispute. Wall Street Journal, 18 Aug 2013. http://online.wsj.com/article/SB10001424127887323455104579015291810290818.html
Huml RA (2010) Introduction to the due diligence process. RAPS, p 126, copyright 2010, ISBN: 0-9787006-4-3
Huml RA (2012) Pharmaceutical competitive intelligence for the regulatory affairs professional. Springer, p 82, Copyright 2012; ISBN: 978-1-4614-3681-2 (Paperback); ISBN 978-1-4614-3682-9 (eBook)
Quintiles press release (2013) Quintiles Infosario receives Computerworld Data+ Editor’s Choice Award. 26 Aug 2013. http://www.quintiles.com/library/press-releases/quintiles-infosario-receives-computerworld-data-editors-choiceaward/. Accessed 24 Jul 2014
Jay E (2010) Viagra and other drugs discovered by accident. BBC News, 20 Jan 2010. http://news.bbc.co.uk/2/hi/health/8466118.stm. Accessed 24 Jul 2014
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Sax, F.(., Huml, R.A., Ng-Cashin, J. (2015). Clinical Aspects of Pharmaceutical Portfolio Management. In: Antonijevic, Z. (eds) Optimization of Pharmaceutical R&D Programs and Portfolios. Springer, Cham. https://doi.org/10.1007/978-3-319-09075-7_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-09075-7_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-09074-0
Online ISBN: 978-3-319-09075-7
eBook Packages: Business and EconomicsBusiness and Management (R0)